October 28, 2020
- Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM? (HTML)
- Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis (HTML)
- Investigating the potential impact of post translational modification of auto-antigens by tissue transglutaminase on humoral islet autoimmunity in type 1 diabetes (HTML)
- Molecular and Functional Diversity of Distinct Subpopulations of the Stressed Insulin-Secreting Cell’s Vesiculome (HTML)
- Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity (HTML)
- Two types of fulminant type 1 diabetes mellitus: immune checkpoint inhibitor related and conventional (HTML)
- Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab (HTML)
- Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm
- Performance of the Prototype NovioSense Noninvasive Biosensor for Tear Glucose in Type 1 Diabetes (HTML)
- Left atrial dysfunction and stiffness in pediatric and adult patients with type 1 diabetes mellitus assessed with speckle tracking echocardiography (HTML)
- Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes (HTML)
- Possible involvement of autoimmunity in fulminant type 1 diabetes
- The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies (HTML)
- Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes (HTML)
